Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.6.3 replaces v3.6.2 on the page, signaling a small update to the page's version history rather than a substantive change to the study details.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a minor update to the page metadata. This does not modify study content, eligibility criteria, or results.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRecruitment status indicates the study is no longer enrolling participants. The page now includes new help sections ('How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a revision label (Revision: v3.6.0).SummaryDifference0.3%

- Check35 days agoChange DetectedThe page's revision label updated from v3.5.4 to v3.5.5, indicating a newer version of the study documentation has been published.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision: v3.5.4 replaces the previous Revision: v3.5.3 on this page, indicating a new version of the study record. This update reflects minor edits or clarifications to the document rather than changes to the study content itself.SummaryDifference0.0%

- Check78 days agoChange DetectedThe page’s displayed release/version number was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.